Johan Edewaard CEO

Roles

05.01.202608.01.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
08.01.2026ODI Pharma AB (publ) Stockholm
Bought — open marketAcquisition
10,000SEK 3.76
SEK 37,600.00
05.01.2026ODI Pharma AB (publ) Stockholm
Bought — open marketAcquisition
3,471SEK 3.00
SEK 10,413.00